Immediate Impact
1 by Nobel laureates 70 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
2025 Standout
Works of Cindy Yun being referenced
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Cindy Yun | 269 | 165 | 91 | 13 | 317 | |
| Chelsea Andrews | 279 | 119 | 58 | 17 | 309 | |
| Misty Dawn Shields | 167 | 125 | 66 | 17 | 281 | |
| Alexander Golf | 309 | 181 | 61 | 13 | 342 | |
| Linpeng Zheng | 198 | 144 | 69 | 15 | 290 | |
| Ana B. Galván | 108 | 135 | 71 | 13 | 300 | |
| Ignazio Martellucci | 273 | 103 | 71 | 16 | 346 | |
| Bharathi Vennapusa | 229 | 105 | 67 | 13 | 298 | |
| Paola Poletti | 213 | 125 | 41 | 17 | 325 | |
| Lorenzo Ruggieri | 233 | 92 | 38 | 13 | 293 | |
| Longgang Cui | 290 | 157 | 69 | 15 | 369 |
All Works
Loading papers...